CA3187662A1 - Systeme et procede de prevention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodegeneratives - Google Patents
Systeme et procede de prevention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodegenerativesInfo
- Publication number
- CA3187662A1 CA3187662A1 CA3187662A CA3187662A CA3187662A1 CA 3187662 A1 CA3187662 A1 CA 3187662A1 CA 3187662 A CA3187662 A CA 3187662A CA 3187662 A CA3187662 A CA 3187662A CA 3187662 A1 CA3187662 A1 CA 3187662A1
- Authority
- CA
- Canada
- Prior art keywords
- para
- brain
- tissue
- treatment
- pulsed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title claims abstract description 35
- 230000004770 neurodegeneration Effects 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims description 51
- 210000004556 brain Anatomy 0.000 claims abstract description 70
- 239000012530 fluid Substances 0.000 claims abstract description 28
- 238000011282 treatment Methods 0.000 claims description 171
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 81
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 81
- 230000004913 activation Effects 0.000 claims description 50
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 102000004169 proteins and genes Human genes 0.000 claims description 33
- 238000010521 absorption reaction Methods 0.000 claims description 30
- 230000003993 interaction Effects 0.000 claims description 22
- 102000013455 Amyloid beta-Peptides Human genes 0.000 claims description 18
- 108010090849 Amyloid beta-Peptides Proteins 0.000 claims description 18
- 208000024827 Alzheimer disease Diseases 0.000 claims description 17
- 210000005013 brain tissue Anatomy 0.000 claims description 12
- 230000005672 electromagnetic field Effects 0.000 claims description 12
- 230000008499 blood brain barrier function Effects 0.000 claims description 9
- 210000001218 blood-brain barrier Anatomy 0.000 claims description 9
- 102000013498 tau Proteins Human genes 0.000 claims description 9
- 108010026424 tau Proteins Proteins 0.000 claims description 9
- 230000001684 chronic effect Effects 0.000 abstract description 24
- 208000037821 progressive disease Diseases 0.000 abstract description 20
- 238000002560 therapeutic procedure Methods 0.000 abstract description 7
- 230000001681 protective effect Effects 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 211
- 238000002604 ultrasonography Methods 0.000 description 62
- 238000001994 activation Methods 0.000 description 47
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 44
- 201000010099 disease Diseases 0.000 description 42
- 230000000694 effects Effects 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 34
- 230000006378 damage Effects 0.000 description 30
- 210000001525 retina Anatomy 0.000 description 30
- 230000002207 retinal effect Effects 0.000 description 28
- 230000005684 electric field Effects 0.000 description 25
- 230000003287 optical effect Effects 0.000 description 25
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 23
- 230000003321 amplification Effects 0.000 description 22
- 230000008901 benefit Effects 0.000 description 22
- 238000003199 nucleic acid amplification method Methods 0.000 description 22
- 230000014509 gene expression Effects 0.000 description 20
- 230000007246 mechanism Effects 0.000 description 20
- 230000005670 electromagnetic radiation Effects 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 230000001225 therapeutic effect Effects 0.000 description 18
- 239000004020 conductor Substances 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- 230000005855 radiation Effects 0.000 description 16
- 230000008439 repair process Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 101100218464 Haloarcula sp. (strain arg-2 / Andes heights) cop2 gene Proteins 0.000 description 14
- 210000001124 body fluid Anatomy 0.000 description 14
- 230000001413 cellular effect Effects 0.000 description 14
- 210000003128 head Anatomy 0.000 description 14
- 208000017442 Retinal disease Diseases 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 230000005451 protein repair Effects 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000000624 ear auricle Anatomy 0.000 description 12
- 230000007774 longterm Effects 0.000 description 12
- 230000000451 tissue damage Effects 0.000 description 12
- 231100000827 tissue damage Toxicity 0.000 description 12
- 230000002159 abnormal effect Effects 0.000 description 11
- 230000002411 adverse Effects 0.000 description 11
- 238000009792 diffusion process Methods 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- 230000035515 penetration Effects 0.000 description 11
- 230000003915 cell function Effects 0.000 description 10
- 230000000254 damaging effect Effects 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 10
- 230000000649 photocoagulation Effects 0.000 description 10
- 102000004127 Cytokines Human genes 0.000 description 9
- 108090000695 Cytokines Proteins 0.000 description 9
- 230000005856 abnormality Effects 0.000 description 9
- 206010064930 age-related macular degeneration Diseases 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 9
- 208000002780 macular degeneration Diseases 0.000 description 9
- 101100500493 Mus musculus Eapp gene Proteins 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 239000003792 electrolyte Substances 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 230000004393 visual impairment Effects 0.000 description 8
- 206010012689 Diabetic retinopathy Diseases 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000005779 cell damage Effects 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000013307 optical fiber Substances 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 238000001126 phototherapy Methods 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- 208000010412 Glaucoma Diseases 0.000 description 6
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 239000012212 insulator Substances 0.000 description 6
- 208000036971 interstitial lung disease 2 Diseases 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 210000001328 optic nerve Anatomy 0.000 description 6
- 230000002035 prolonged effect Effects 0.000 description 6
- 230000004936 stimulating effect Effects 0.000 description 6
- 230000004304 visual acuity Effects 0.000 description 6
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000004958 brain cell Anatomy 0.000 description 5
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000013532 laser treatment Methods 0.000 description 5
- 231100000518 lethal Toxicity 0.000 description 5
- 230000001665 lethal effect Effects 0.000 description 5
- 230000000324 neuroprotective effect Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 230000000750 progressive effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000011476 stem cell transplantation Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010025421 Macule Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 208000038016 acute inflammation Diseases 0.000 description 4
- 230000006022 acute inflammation Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 208000037887 cell injury Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000037976 chronic inflammation Diseases 0.000 description 4
- 230000006020 chronic inflammation Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 238000009163 protein therapy Methods 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000004243 retinal function Effects 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 3
- 206010057430 Retinal injury Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 229940124599 anti-inflammatory drug Drugs 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000011190 diabetic macular edema Diseases 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- 229940124589 immunosuppressive drug Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 102000001049 Amyloid Human genes 0.000 description 2
- 108010094108 Amyloid Proteins 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000010398 acute inflammatory response Effects 0.000 description 2
- 230000003941 amyloidogenesis Effects 0.000 description 2
- 206010002022 amyloidosis Diseases 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000009395 genetic defect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000017525 heat dissipation Effects 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000005596 ionic collisions Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000003818 metabolic dysfunction Effects 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 230000009826 neoplastic cell growth Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000004768 organ dysfunction Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 210000003994 retinal ganglion cell Anatomy 0.000 description 2
- 238000011268 retreatment Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000033379 Chorioretinopathy Diseases 0.000 description 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010016202 Familial Amyloidosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000031074 Reinjury Diseases 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006933 amyloid-beta aggregation Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000025698 brain inflammatory disease Diseases 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000010001 cellular homeostasis Effects 0.000 description 1
- 230000004637 cellular stress Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000037410 cognitive enhancement Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 239000002772 conduction electron Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000009433 disease-worsening effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000005681 electric displacement field Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004258 retinal degeneration Effects 0.000 description 1
- 230000004262 retinal health Effects 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 201000003772 severe nonproliferative diabetic retinopathy Diseases 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 230000007853 structural degeneration Effects 0.000 description 1
- 210000002301 subretinal fluid Anatomy 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000001585 trabecular meshwork Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
- A61N5/022—Apparatus adapted for a specific treatment
- A61N5/025—Warming the body, e.g. hyperthermia treatment
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Radiation-Therapy Devices (AREA)
- Electrotherapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Système de thérapie protectrice pour des tissus ou des fluides biologiques consistant à appliquer une source d'énergie pulsée à un tissu cible ou à un fluide cible présentant une maladie chronique évolutive ou un risque de présenter une maladie chronique évolutive pour traiter de manière thérapeutique ou prophylactique le tissu cible ou le fluide cible. Une source d'énergie pulsée ayant des paramètres d'énergie sélectionnés peut être appliquée à au cerveau d'un individu qui présente la maladie d'Alzheimer ou une autre maladie neurodégénérative ou qui est susceptible de développer une telle maladie neurodégénérative de façon à prévenir ou à traiter la maladie neurodégénérative.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/984,486 | 2020-08-04 | ||
| US16/984,486 US10894169B2 (en) | 2012-05-25 | 2020-08-04 | System and method for preventing or treating Alzheimer's and other neurodegenerative diseases |
| PCT/US2021/036128 WO2022031362A1 (fr) | 2020-08-04 | 2021-06-07 | Système et procédé de prévention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodégénératives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3187662A1 true CA3187662A1 (fr) | 2022-02-10 |
Family
ID=80117611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3187662A Pending CA3187662A1 (fr) | 2020-08-04 | 2021-06-07 | Systeme et procede de prevention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodegeneratives |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4185376A4 (fr) |
| JP (1) | JP2023544080A (fr) |
| CN (1) | CN116322901A (fr) |
| AU (1) | AU2021321214A1 (fr) |
| BR (1) | BR112023001701A2 (fr) |
| CA (1) | CA3187662A1 (fr) |
| WO (1) | WO2022031362A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114818412B (zh) * | 2022-03-18 | 2022-09-27 | 北京航空航天大学 | 一种人脑受电磁辐射的高精度计算方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9014801B2 (en) * | 2008-03-19 | 2015-04-21 | The Board Of Trustees Of The University Of Illinois | Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response |
| WO2013116235A1 (fr) * | 2012-01-30 | 2013-08-08 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPT OF HEALTH & HUMAN SERVICES | Amélioration de la stimulation transcrânienne par courant continu ou de la stimulation transcrânienne magnétique faisant appel à la modulation synaptique induite par la température |
| US10953241B2 (en) | 2012-05-25 | 2021-03-23 | Ojai Retinal Technology, Llc | Process for providing protective therapy for biological tissues or fluids |
| US9962291B2 (en) | 2012-05-25 | 2018-05-08 | Ojai Retinal Technology, Llc | System and process for neuroprotective therapy for glaucoma |
| WO2014070699A1 (fr) * | 2012-11-01 | 2014-05-08 | Seminex Corporation | Traitements de la peau au laser à intensité variable |
| US9999772B2 (en) * | 2014-04-03 | 2018-06-19 | Pacesetter, Inc. | Systems and method for deep brain stimulation therapy |
| BR112019001348A2 (pt) * | 2016-08-09 | 2019-04-30 | Ojai Retinal Tech Llc | processo para fornecer terapia protetora a tecidos ou fluidos biológicos |
-
2021
- 2021-06-07 JP JP2023507935A patent/JP2023544080A/ja active Pending
- 2021-06-07 WO PCT/US2021/036128 patent/WO2022031362A1/fr active Application Filing
- 2021-06-07 EP EP21854336.1A patent/EP4185376A4/fr active Pending
- 2021-06-07 CN CN202180067995.1A patent/CN116322901A/zh active Pending
- 2021-06-07 BR BR112023001701A patent/BR112023001701A2/pt not_active Application Discontinuation
- 2021-06-07 CA CA3187662A patent/CA3187662A1/fr active Pending
- 2021-06-07 AU AU2021321214A patent/AU2021321214A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021321214A1 (en) | 2023-02-23 |
| BR112023001701A2 (pt) | 2023-03-28 |
| CN116322901A (zh) | 2023-06-23 |
| WO2022031362A1 (fr) | 2022-02-10 |
| EP4185376A4 (fr) | 2023-11-15 |
| EP4185376A1 (fr) | 2023-05-31 |
| JP2023544080A (ja) | 2023-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10953241B2 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US10531908B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US10894169B2 (en) | System and method for preventing or treating Alzheimer's and other neurodegenerative diseases | |
| US20170203132A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| AU2020213374B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| JP2022119821A5 (fr) | ||
| US11033749B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| US20210346712A1 (en) | System and process of utilizing microwave energy for treating biological tissue | |
| CA3187662A1 (fr) | Systeme et procede de prevention ou de traitement de la maladie d'alzheimer et d'autres maladies neurodegeneratives | |
| CA3030483A1 (fr) | Processus destine a fournir une therapie protectrice pour des tissus ou de fluides biologiques | |
| AU2018236202B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| US20230103544A1 (en) | System and process for utilizing energy for neuroregeneration | |
| WO2024118164A1 (fr) | Système et procédé d'utilisation d'énergie pour la neurorégénération | |
| CA3091103A1 (fr) | Systeme et procede d'utilisation d'energie pour traiter un tissu biologique | |
| WO2018169560A1 (fr) | Système et procédé utilisant une énergie pulsée pour traiter un tissu biologique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230719 |
|
| EEER | Examination request |
Effective date: 20230719 |